HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Fitzgerald Selected Research

Arthritis (Polyarthritis)

2/2012Joint tenderness and swelling in biologic-treated inflammatory arthritis patients - a tricky trade off?
7/2010Synovial tissue hypoxia and inflammation in vivo.
2/2010Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.
1/2010Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
5/2008Differential expression of syndecans and glypicans in chronically inflamed synovium.
11/2003Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.
10/2001Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
1/2000Serum amyloid A in the assessment of early inflammatory arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Fitzgerald Research Topics

Disease

8Arthritis (Polyarthritis)
02/2012 - 01/2000
7Psoriatic Arthritis
11/2020 - 11/2003
4Necrosis
10/2018 - 12/2006
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2014 - 12/2006
4Rheumatoid Arthritis
02/2012 - 04/2001
2Inflammation (Inflammations)
07/2010 - 10/2001
1Infections
01/2014
1Axial Spondyloarthritis
01/2014
1Ankylosing Spondylitis
01/2014
1Tuberculosis (Tuberculoses)
01/2014
1Periostitis
02/2012
1Pain (Aches)
02/2010
1Rheumatic Diseases (Rheumatism)
02/2010
1Latent Tuberculosis
01/2010
1Synovitis
11/2003
1Systemic Scleroderma (Systemic Sclerosis)
04/2001

Drug/Important Bio-Agent (IBA)

3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 12/2006
2Biomarkers (Surrogate Marker)IBA
11/2020 - 11/2003
2Interferon-gamma (Interferon, gamma)IBA
07/2010 - 01/2010
2CytokinesIBA
07/2010 - 01/2006
1Biological ProductsIBA
02/2012
1Tumor Necrosis Factor InhibitorsIBA
02/2012
1Etanercept (Enbrel)FDA Link
05/2011
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
07/2010
1Oxygen (Dioxygen)IBA
07/2010
1Interleukin-8 (Interleukin 8)IBA
07/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2010
1Interleukin-6 (Interleukin 6)IBA
07/2010
1ametantrone (HAQ)IBA
02/2010
1Adalimumab (Humira)FDA Link
02/2010
1C-Reactive ProteinIBA
02/2010
1GlucocorticoidsIBA
02/2010
1Prostaglandins AIBA
02/2010
1Syndecan-1 (Syndecan 1)IBA
05/2008
1GlypicansIBA
05/2008
1Infliximab (Remicade)FDA Link
12/2006
1SurvivinIBA
12/2006
1Inhibitor of Apoptosis ProteinsIBA
12/2006
1ChemokinesIBA
01/2006
1Cell Adhesion MoleculesIBA
01/2006
1S100A12 ProteinIBA
11/2003
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
10/2001
1Matrix Metalloproteinase 3 (Stromelysin 1)IBA
10/2001
1Tissue Inhibitor of MetalloproteinasesIBA
10/2001
1Rheumatoid FactorIBA
04/2001
1Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2000

Therapy/Procedure

6Therapeutics
10/2018 - 12/2006